-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In healthy people, hematopoietic cloning with a sudden leukemia occurs with age, but rarely progresses into acute myeloid leukemia (AML)Recent evidence suggests that microenvironments may play an important role in human AML dynamicsin order to study this possibility, Elizabeth Bulaeva et altested the combined and individual effects of cancer genes (c-MYC) and IL-3, GM-CSF, and SCF exposure to xenotransplant
immunodeficiency mice in experimental human AMLpreliminary experiments showed that the normal human CD34 plus blood cells that transfected the MEC to immune-deficiency mice, these cells will quickly develop lethal amplification, phenotype and transcription spectrum are similar to human AML cells, but only in genetically modified mice that produce IL3, GM-CSF and SCF, or in mice that use co-dye-transmission strategies to expose cells to IL3 or GM-CSFin the absence of IL3, GM-CSF, or SCF, MYC-human cells can produce normal lymphatic and myelin cells for several months in transplanted mice, but when transferred to mice that produce human cytokines, MYC-cells quickly produce AMLthese findings underscore the key role of these cytokines (IL3, GM-CSF, and SCF) in activating the malignant state of normally differentiated artificial blood cells
